70 related articles for article (PubMed ID: 11911273)
1. Carboplatin AUC and gamma-glutamylcysteine synthetase gene expression in peripheral mononuclear cells of lung cancer patients.
Oguri T; Isobe T; Mitsuta K; Masuda K; Daga H; Ishikawa N; Fujitaka K; Miyazaki M; Kohno N
Anticancer Res; 2001; 21(6A):3933-6. PubMed ID: 11911273
[TBL] [Abstract][Full Text] [Related]
2. Induction of gamma-glutamylcysteine synthetase gene expression by platinum drugs in peripheral mononuclear cells of lung cancer patients.
Oguri T; Fujiwara Y; Miyazaki M; Takahashi T; Kurata T; Yokozaki M; Ohashi N; Isobe T; Katoh O; Yamakido M
Ann Oncol; 1999 Apr; 10(4):455-60. PubMed ID: 10370789
[TBL] [Abstract][Full Text] [Related]
3. [Effects of deltamethrin on gene expression of some antioxidase, gamma glutamylcysteine synthetase and NFE2 related factor 2 (Nrf2) in brain tissue].
Li HY; Shi N; Dai ZH; Zhong YF; Wu SY
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 May; 24(5):273-7. PubMed ID: 16737586
[TBL] [Abstract][Full Text] [Related]
4. Proximal 5'-flanking sequence of the human gamma-glutamylcysteine synthetase heavy subunit gene is involved in cisplatin-induced transcriptional up-regulation in a lung cancer cell line SBC-3.
Tomonari A; Nishio K; Kurokawa H; Fukumoto H; Fukuoka K; Iwamoto Y; Usuda J; Suzuki T; Itakura M; Saijo N
Biochem Biophys Res Commun; 1997 Jul; 236(3):616-21. PubMed ID: 9245699
[TBL] [Abstract][Full Text] [Related]
5. [Time course of gene expression of gamma-glutamylcysteine synthetase subunit and Nrf2 in brain tissues of rats exposed by deltamethrin].
Li HY; Shi N; Zhong YF; Dai ZH
Wei Sheng Yan Jiu; 2006 Mar; 35(2):130-4. PubMed ID: 16758951
[TBL] [Abstract][Full Text] [Related]
6. [Cigarette smoking coacervate up-regulates the expression of gamma-glutamylcysteine synthetase in alveolar epithelial cells mediated by activator protein-1].
Zou ZX; Ran PX
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3289-92. PubMed ID: 16409822
[TBL] [Abstract][Full Text] [Related]
7. Phase I study of G3139, a bcl-2 antisense oligonucleotide, combined with carboplatin and etoposide in patients with small-cell lung cancer.
Rudin CM; Kozloff M; Hoffman PC; Edelman MJ; Karnauskas R; Tomek R; Szeto L; Vokes EE
J Clin Oncol; 2004 Mar; 22(6):1110-7. PubMed ID: 15020613
[TBL] [Abstract][Full Text] [Related]
8. Association between expression of the MRP3 gene and exposure to platinum drugs in lung cancer.
Oguri T; Isobe T; Fujitaka K; Ishikawa N; Kohno N
Int J Cancer; 2001 Aug; 93(4):584-9. PubMed ID: 11477564
[TBL] [Abstract][Full Text] [Related]
9. Role of gamma-glutamyl cysteine synthetase (gamma-GCS) gene expression as marker of drug sensitivity in acute myeloid leukemias.
Carnicer MJ; Bernardini S; Bellincampi L; Noguera NI; Nuccetelli M; Ammatuna E; Breccia M; Lo-Coco F; Federici G
Clin Chim Acta; 2006 Mar; 365(1-2):342-5. PubMed ID: 16239001
[TBL] [Abstract][Full Text] [Related]
10. In vitro sensitivity to platinum-derived drugs is associated with expression of thymidylate synthase and dihydropyrimidine dehydrogenase in human lung cancer.
Takizawa M; Kawakami K; Obata T; Matsumoto I; Ohta Y; Oda M; Sasaki T; Watanabe G
Oncol Rep; 2006 Jun; 15(6):1533-9. PubMed ID: 16685392
[TBL] [Abstract][Full Text] [Related]
11. The modifier subunit of glutamate cysteine ligase relates to cisplatin resistance in human small cell lung cancer xenografts in vivo.
Nishi M; Abe Y; Fujimori S; Hamamoto A; Inoue Y; Miyazaki N; Oida Y; Ikoma N; Ohnishi Y; Yamazaki H; Ueyama Y; Nakamura M
Oncol Rep; 2005 Aug; 14(2):421-4. PubMed ID: 16012725
[TBL] [Abstract][Full Text] [Related]
12. A phase I trial defining the maximum tolerated systemic exposure of topotecan in combination with Carboplatin and Etoposide in extensive stage small cell lung cancer.
Gillenwater HH; McCune JS; Lindley C; Faucette S; Shord S; Donahue A; Socinski MA; Stewart CF; Zamboni WC; Kirstein MN; Moore D
Cancer Invest; 2005; 23(6):511-9. PubMed ID: 16203659
[TBL] [Abstract][Full Text] [Related]
13. Gamma-glutamylcysteine synthetase-based selection strategy for gene therapy of chronic granulomatous disease and graft-vs.-host disease.
Rappa G; Anzanello F; Alexeyev M; Fodstad O; Lorico A
Eur J Haematol; 2007 May; 78(5):440-8. PubMed ID: 17331133
[TBL] [Abstract][Full Text] [Related]
14. [Intraperitoneal and intrathoracic administration of hydroxyapatite-carboplatin (HAp-CBDCA)].
Mohri N; Mizuno I; Akamo Y; Takeyama H; Manabe T
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1791-3. PubMed ID: 10560396
[TBL] [Abstract][Full Text] [Related]
15. Arsenic induces oxidative stress and activates stress gene expressions in cultured lung epithelial cells.
Li M; Cai JF; Chiu JF
J Cell Biochem; 2002; 87(1):29-38. PubMed ID: 12210719
[TBL] [Abstract][Full Text] [Related]
16. The subunits of glutamate cysteine ligase enhance cisplatin resistance in human non-small cell lung cancer xenografts in vivo.
Fujimori S; Abe Y; Nishi M; Hamamoto A; Inoue Y; Ohnishi Y; Nishime C; Matsumoto H; Yamazaki H; Kijima H; Ueyama Y; Inoue H; Nakamura M
Int J Oncol; 2004 Aug; 25(2):413-8. PubMed ID: 15254739
[TBL] [Abstract][Full Text] [Related]
17. [Clinical pharmacokinetics of carboplatin and MCNU in malignant brain tumor and normal brain tissues].
Shinohara C; Matsumoto K; Kuriyama M; Adachi H; Ono Y; Higashi H; Furuta T; Ohmoto T
Gan To Kagaku Ryoho; 1994 Jul; 21(8):1163-8. PubMed ID: 8031157
[TBL] [Abstract][Full Text] [Related]
18. Treatment of peritoneal carcinomatosis using carboplatin-loaded hydroxyapatite particles.
Takeyama H; Mohri N; Mizuno I; Akamo Y; Sawai H; Manabe T; Yotsuyanagi T; Nakamura S
Anticancer Res; 2006; 26(6B):4603-6. PubMed ID: 17201184
[TBL] [Abstract][Full Text] [Related]
19. Expression of gamma-glutamylcysteine synthetase (gamma-GCS) and multidrug resistance-associated protein (MRP), but not human canalicular multispecific organic anion transporter (cMOAT), genes correlates with exposure of human lung cancers to platinum drugs.
Oguri T; Fujiwara Y; Isobe T; Katoh O; Watanabe H; Yamakido M
Br J Cancer; 1998 Apr; 77(7):1089-96. PubMed ID: 9569044
[TBL] [Abstract][Full Text] [Related]
20. Phase I and pharmacologic study of sequential topotecan-carboplatin-etoposide in patients with extensive stage small cell lung cancer.
Miller AA; Al Omari A; Murry DJ; Case D
Lung Cancer; 2006 Dec; 54(3):379-85. PubMed ID: 17049403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
